Key result
In-hospital worsening heart failure linked to ~77% higher 180-day mortality regardless of timing or treatment.
Why the study?
Does the time of occurrence (early vs. late) or intensity of therapy (high vs. low) for in-hospital worsening heart failure affect 60-day morbidity and 180-day mortality in patients hospitalized with acute heart failure?
Cohort (n=1,879)
Yes
Does the time of occurrence (early vs. late) or intensity of therapy (high vs. low) for in-hospital worsening heart failure affect 60-day morbidity and 180-day mortality in patients hospitalized with acute heart failure?
In-hospital worsening heart failure during acute heart failure admission strongly predicts 180-day mortality regardless of whether it occurs early or late or requires low- or high-intensity therapy.
Answers are grounded in this paper and cite their sources.
In-hospital worsening heart failure flags elevated 180-day mortality risk in acute HF; leaves open whether targeted interventions improve outcomes.
BACKGROUND: Worsening heart failure (WHF) symptoms despite initial therapy during admission for acute heart failure (AHF) is associated with worse outcomes. The association between the time of the WHF event and the intensity of WHF therapy with outcomes is unknown. METHODS AND RESULTS: In the PROTECT trial of 2033 AHF patients, we investigated the association between time of occurrence of WHF and intensity of therapy, with subsequent outcomes. WHF was defined by standardized, physician-determined assessment. Early WHF was defined as occurring on days 2-3 and late on days 4-7. Low intensity included restarting/increasing diuretics or vasodilators and high intensity included initiation of inotropes, vasopressors, inodilators, or mechanical support. Outcomes were death or cardiovascular/renal hospitalization over 60 days and death over 180 days. Of the 1879 patients with complete follow-up after day 7, 12.7% (n = 238) experienced WHF: 47.9% early and 52.1% late. Treatment intensity was low in 72.3% and high in 24.8% (2.9% missing). After adjusting for baseline predictors of outcome, WHF was associated with a trend toward increased 60-day death or cardiovascular/renal hospitalization [hazard ratio (HR) 1.26; 95% confidence interval (CI) 0.99-1.60; P = 0.063] and increased 180-day death (HR 1.77; 95% CI 1.33-2.34; P < 0.001). There was no evidence of a differential association between the time of occurrence of WHF and outcomes. High-intensity therapy was not significantly associated with increased event rates (180-day mortality: HR 1.44; 95% CI 0.80-2.59 vs. low). CONCLUSIONS: Inhospital WHF was associated with increased 180-day death. The time of occurrence and intensity of WHF therapy may provide less prognostic information than whether or not WHF occurred.
No takes yet. Share an insight, caveat, or question.
Mentz et al. (2015) conducted a cohort in Acute heart failure with mild or moderate renal impairment (n=1,879). In-hospital worsening heart failure (WHF), including early (days 2-3) vs. late (days 4-7) occurrence and high- vs. low-intensity therapy vs. No worsening heart failure (or early WHF / low-intensity therapy in subgroup comparisons) was evaluated on 180-day all-cause death (HR 1.77, 95% CI 1.33-2.34, p=<0.001). In-hospital worsening heart failure was associated with increased 180-day mortality regardless of time of occurrence or therapy intensity.
Synapse has enriched 10 related papers. Consider them for comparative context: